The authors would like to report an error that appeared in Figure 1 of a recently published article [1]. There should be no indication of a substitution at M204V/I associated with tenofovir. The corrected version is shown below (Figure 1). The authors apologize for this mistake.
References
1.
PerrilloR.P., MarcellinP.Effect of newer oral antiviral agents on future therapy of chronic hepatitis B.Antivir Ther2010; 15: 13–22.
2.
LocarniniS., HatzakisA., HeathcoteJ.Management of antiviral resistance in patients with chronic hepatitis B.Antivir Ther2004; 9: 679–693.